a. Using our experience conjugation chemistries on fullerenes (Diels-Alder cycloaddition), we will construct CNW conjugates using CVD grown nanotubes and herceptin. (Months 1 -4) b. We will demonstrate that the conjugates' photo-ablative properties are significantly superior to intercellular forms of ablative therapeutics using in situ cell studies (cell lines listed below). (Month 5) a. The interaction of the Herceptin-CNW conjugate will be tested in the immunoblotting and immunofluorescence experiments. We will employ HER-2 negative breast cancer cells (MCF-7 and MDA MB 231) and HER-2 positive cells (SK-Br-3 and BT474), and a Herceptin resistant BT474 cell line. (Month 6 -8) b. We will demonstrate that the conjugated nanotubes phototheramlly-ablate Herceptin positive breast cancer cells orthotopically implanted in athymic nude mice. (Month 9 -10) c. We will determine the optimized concentration of the conjugate for given depths within the mice. Accomplishments:
To establish the feasibility of conferring aqueous solubility to MWNTs using DNA which could consequently be used in targeting, and to investigate to what extent DNA-encased MWNTs are useful for thermal ablation of malignant tissue. Multi-walled carbon nanotubes (MWNTs), strongly absorb near infrared (nIR) radiation and efficiently convert absorbed energy to released heat which can be used for localized hyperthermia applications. The relative efficiency of conversion of nIR irradiation into heat for DNA-encased MWNTs relative to non-DNA-encased MWNTs and other materials is an important consideration for identifying which type of nanomaterial is best-suited for in vivo thermal ablation approaches (Boldor et al., 2008) . We have undertaken an analysis of the time-, power-, and concentration-dependence of heat generation from DNA-encased MWNTs. We demonstrate that DNA-encased MWNTs produce larger amounts of heat than non-DNA-encased MWNTs indicating that DNA-encasement may increase the utility of MWNTs for thermal ablative applications. Further, we demonstrate that DNA-encased MWNTs efficiently eradicate tumor xenografts in vivo in a mouse model of human cancer. Complete tumor eradication was achieved with a single treatment under conditions that resulted in no injury or damage to normal tissues. These finding demonstrate that DNA-encased MWNTs are useful for development of molecularly-targeted nanoparticles for selective thermal ablation of malignant tissue in humans.
We demonstrate that DNA-encasement efficiently solubilizes MWNTs and that DNA-encased MWNTs can be used to sensitize tumor tissue to nIR irradiation and used to completely eradicate a tumor mass. Heat is generated upon irradiation of DNA-encased MWNTs with a linear dependence on both laser power and time. A single treatment consisting of intratumoral injection of MWNTs (100 l of a 500 g/mL solution) followed by laser irradiation at 1064 nm, 2.5 W/cm 2 completely eradicated PC3 xenograft tumors in 8/8
(100%) of nu/nu mice. Control tumors that received only MWNT injection or laser irradiation showed tumor growth rates indistinguishable from control tumors that received no treatment. Non-malignant tissues displayed no long term damage from treatment. The results demonstrate that DNA-encased MWNTs can be used effectively for selective thermal ablation for cancer treatment.
Report on Task 1: Development of Herceptin-CNWs in cell culture:
a. Using our experience conjugation chemistries on fullerenes (Diels-Alder cycloaddition), we will construct CNW conjugates using CVD grown nanotubes and herceptin. (Months 1 -4) b. We will demonstrate that the conjugates' photo-ablative properties are significantly superior to intercellular forms of ablative therapeutics using in situ cell studies (cell lines listed below). (Month 5) Task1a.
Herceptin conjugated Nitrogen doped Multiwalled Carbon Nanotubes were created using standard Diels-Alder Chemistries. A wide variety of N-MWNTs were used for this but in all cases it was found that the adduct denatured around the nanotube forming crystalline formations. This resulted in nanotube-protein precipitates and insolubility. Possible ways around this included using longer tethers for the adduct. This was tried but coupling chemistries suffered from steric considerations for such large molecules.
After the first four months of this, we made the decision to move to a different targeting meaty, replacing herceptin with something else. Since the point of the experiment was to show that N-MWNTs could be targeted to tumor tissues or cell lines, use of another targeting species was deemed to not significantly alter the aims of the work and would provide for a faster route toward demonstrations in the time frames allotted. Our second approach was more successful, the use of aptamers.
Details of the successful approach to building N-MWNTs with targeting molecule:
Raw, carbon vapor deposition (CVD) MWNTs (0.05 mg/mL) were sonicated in a 4µM (0.05mg/mL) aqueous solution of singlestranded DNA (ssDNA; e.g. d(GT) 40 ) at 20 o C for 50 min using a bath sonicator to yield a solution of MWNTs non-covalently associated with ssDNA (DNA-encased MWNTs). The mixture was maintained at room temperature overnight followed by centrifugation at 2500 x g for 30 min to pellet MWNT aggregates and any insoluble material. The resulting translucent supernatant consisting of DNA-encased MWNTs was filtered through a 100-kDa molecular weight cutoff (MWCO) filters (Millipore) and extensively washed with 15 mL dH 2 O to remove any unbound ssDNA. The filtration and washing steps were repeated 10 times and the efficiency of removal for free DNA was confirmed by no detectable absorbance of the final filtrates at 260 nm. The concentration of MWNT solution was determined by optical absorbance from a pre-established standard curve at 808 nm obtained using a DU800
UV-Vis spectrophotometer (Beckman Coulter). The fluorescently-labeled MWNT-DNA complex was prepared in an identical manner as for non-fluorescent complex except the ssDNA was fluorescently-labeled at the 5' terminus with FAM (Glenn Research).
We used Microscopic Characterization of Aptamer Functionalized N-MWNT to "see" our result.
AFM images were acquired under ambient conditions using a Nanoscope IIIA (Veeco Instruments, Plainview, NY) in tapping mode using silicon cantilevers (Nanosensor TM , type PPP-NCLR-W, force constant k = 21-98 N/m, NanoAndMore, Lady's Island, SC).
Surfaces for AFM imaging were prepared by depositing 50 mM MgCl 2 onto freshly cleaved ruby muscovite mica surface (Paramount Corporation, NY) and allowed to dry in air. The mica surface was thoroughly rinsed with de-ionized water (Milli-Q Watersystem, Millipore Corp. Bedford, MA) to remove excess salt, and then dried using a gentle stream of Nitrogen gas. A 20 μL drop of DNA-MWNT solution (5 μg/mL) was deposited on the substrate and air-dried. The length and diameter of the tubes was analyzed using standard Nanoscope software (version 6.13).
For scanning electron microscopy (SEM), freshly cleaved mica was treated with 100 mM MgCl 2 and washed thoroughly with distilled water to remove excess salt. A 5µl drop of 25 µg/ml MWNT:DNA solution was then evenly dispersed on the mica surface and allowed to dry . The mica with dried MWNT:DNA complex was then pasted onto a stainless steel slab using silver paint. The mica surface on the slab was then sputter-coated with a very thin layer of gold-palladium mixture followed by drying. SEM images were obtained using a JEOL (JSM -6330 F) field emission scanning electron microscope under a high vacuum conditions, using secondary electron emission mode at a working distance of 10 mm, a 12 µA probe current, and an accelerating voltage of 2.00 kV.
AFM and SEM images of DNA-encased MWNTs were obtained in order to assess to what extent aqueous solutions of DNA-encased
MWNTs were mono-dispersed and to assess the range of MWNT size distributions in the DNA-encased samples. Fig. 1 shows a typical AFM image of a DNA-encased MWNT sample. It can be seen that the nanotubes are mostly well dispersed, with many single nanotubes and some small aggregates consisting of a few MWNTs each with clearly distinguishable nanotubes that touch each other.
The presence of DNA is seen as a thickening of the MWNTs. The SEM images display comparable physical properties as those observed in the AFM images ( Fig. 1 ). It can also be seen that the tubes have a range of lengths and diameters, and that most of them are curved. Continuous variations in NT curvature have been attributed to elasticity while bends in MWNT structures may be caused by topological defects (Han et al., 1998) . Only a few globular features are visible. A more detailed analysis of nanotube morphology is shown in Fig. 1b -d. The nanotubes had an average diameter of 49 nm, an average length of 571 nm, and an average aspect ratio (length/diameter) of 13. DNA functionalized MWNTs were characterized by optical absorption spectroscopy and Raman spectroscopy. MWNTs solubilized with polyethylene glycol (PEG) were used as an aqueous-soluble control. Optical absorption spectra for the DNA-encased and PEGsolubilized MWNTs were obtained by using a dual-beam Perkin Elmer λ 19 UV-Vis-NIR spectrophotometer. The wavelength range 250 -1400 nm was scanned at 2.5 nm/s.
Raman spectra were acquired using a Deltanu Advantage 532 Raman spectrometer. The region from 3400 -200 cm -1 was scanned at 532 nm excitation. Raman spectra of non-DNA complexed MWNT was obtained by placing a dry powder sample of MWNT in a capillary glass tube and Raman spectra of DNA-encased MWNTs were obtained in aqueous solution using a glass cuvette.
The optical spectroscopy and Raman spectral properties of DNA-encased MWNTs were analyzed to determine to what extent DNAencasement altered the physical properties of MWNTs. Shown in Figure 1a , absorption and scattering characteristics for aqueous solutions of DNA-encased MWNTs and PEG-solubilized MWNTs are compared. For both preparations, the expected 1/ 4 scattering dominates any specific absorption features of the DNA nucleobases (Murakami et al., 2005; Hughes et al., 2007) . Optical absorbance spectroscopy in the 400 -800 nm range did not reveal discrete absorbance bands for DNA-encased MWNTs that are characteristic of van Hove singularities (Carlson and Krauss, 2008) . These absorbance bands also were not detected for MWNTs solubilized using PEG. Thus, the lack of detection probably arises from factors associated with the manufacture and purification of the MWNTs (Brennan et al., 2003; Pratap et al., 2005) rather than as a consequence of DNA complex formation with MWNTs.
Raman spectroscopy of the DNA-encased MWNTs revealed the presence of D, G, and G' bands that are characteristic of all graphitic materials ( In vitro Heating of DNA-encased MWNTs was tested. The heat emitted following near infrared (nIR) irradiation of aqueous solutions of DNA-encased MWNTs and MWNTs that had not been solubilized with DNA were evaluated by measuring the change in temperature for the aqueous solution using a digital thermometer. The 1 mL MWNT solutions were prepared at seven concentrations
(1 -100 g/mL) and placed in sealed nIR-transparent glass cuvettes fitted with a micro temperature probe in the solution. Each sample was then irradiated at 1064 nm using a Photonix nIR laser system at a fixed power (2, 3, or 4 W/cm 2 ) for a fixed duration (30, 50, or 70 s). The initial temperature of each solution was recorded prior to irradiation and both the final temperature when laser power was turned off and the maximal temperature reached which occurred several seconds after turning laser power off were recorded.
Temperature was monitored using a digital continuous temperature monitoring system. The statistical significance of the measured temperature increases for samples of DNA-encased MWNTs and non-DNA encased MWNTs were analyzed using SAS v.
The extent of heating for aqueous solutions of DNA-encased MWNTs was evaluated to determine if encasing the MWNTs in DNA alters the utility of MWNTs as transducers of irradiated energy into heat. Aqueous solutions of DNA-encased MWNTs or MWNTs that had not been DNA-encased were irradiated at 1064 nm using a Photonics nIR laser system. Sample heating was evaluated for a range of MWNT concentrations (1 -100 g/mL) at three different power levels (2, 3, 4 W) and for times ranging from 25 -70 s.
Representative graphs from these experiments are included in Fig. 4. For a given power level and time of irradiation, the DNA-encased MWNTs resulted in greater heating of the sample than that which occurred following irradiation of the same concentration of non-DNA-encased MWNTs (Fig. 4) . Statistical analysis of the data revealed the heating of the DNA-encased MWNTs solutions was significantly greater than occurred for the non-DNA-encased
MWNTs over a broad range of times, power levels, and concentrations. For example pairwise comparison of the mean values for DNA-encased MWNTs and non-DNA-encased MWNTs, both at a concentration of 10 g/mL, for an irradiation time of 25 s, and irradiation power of 3 W revealed a significant difference (p < 0.0001). Significant differences were observed over a wide-range of concentrations as well as for the full range of power levels and irradiation times evaluated. Thus, encasing the MWNTs in DNA does not reduce the amount of heat generated and for most conditions evaluated, significantly increased the amount of heat generated following laser irradiation.
In some cases, the differential heating of DNA-encased MWNTs relative to non-DNA-encased MWNTs was substantial. In contrast to the linear-dependence of heat generation on time for a given concentration of DNA-encased MWNTs and power level of irradiation, the concentration-dependence of heat production for a given time and power level was non-linear at concentrations greater than approximately 10 g/mL (Fig. 5 c,d) . Further, the graphs indicate clear evidence of saturation (i.e. no further increase in temperature rise) at concentrations greater than 50 g/mL. Interestingly, saturation was not evident for the non-DNA-encased
MWNTs relative to the DNA-encased MWNTs (Fig 5 c,d ). The physical basis for the differential concentration-dependent saturability of DNA-encased MWNTs relative to non-DNA-encased MWNTs is not known at present. The greater heat production for a given concentration of DNA-encased MWNTs relative to non-DNA-encased MWNTs is consistent with DNA-encasing reducing aggregation and with greater heat production per MWNT when in a non-aggregated state. The non-DNA-encased MWNTs continue to display proportionally greater heat production as concentration is increased indicating that aggregates of non-DNA-encased
MWNTs are capable of transducing laser irradiation into heat. These data suggest that DNA-encasing MWNTs alters the physical properties of MWNT aggregates that form at higher MWNT concentrations.
The power dependence of heat generation for a given time and concentration was linear for both DNA-encased and non-DNA-encased MWNTs (Fig 5 e,f) . Doubling of the laser power (from 2 to 4 W) approximately doubled the temperature increase for concentrations of DNA-encased MWNTs less than 25 g/mL. Higher concentrations of DNA-encased MWNTs displayed identical power dependencies to one another. The power dependency for non-DNA-encased MWNT was also linear except for the highest concentration, 100 g/mL, which consistently showed a greater temperature rise between 2 and 3 W compared to between 3 and 4 W.
The slope of the power dependence for non-DNA-encased MWNTs was less steep than for DNA-encased MWNTs. Thus, for a given (non-saturating) concentration of MWNTs (e.g. 10 g/mL), the temperature rise associated with the DNA-encased MWNTs was greater than for the non-DNA-encased MWNTs at both low and high power, however the differential was enhanced at higher power levels (Fig 5 e,f) .
Figure 4: in vitro heating
Cell death in MCF7 and MDA MB 231 as well as SK-Br-3 and BT474 cancer cell lines was monitored using fluorescently tagged cells. Though not shown here, complete cell death was achieved in culture when culture temperatures exceeded 52 o C as we have previously reported. These correlated exactly with the data in figure 4.
Task 2: Targeting and ablation of breast cancer cells in cell culture and mouse models, with the HerceptinCNWs:
a. The interaction of the He rceptin-CNW conjugate will be tested in the i mmunoblotting and immunofluorescence experiments. We will employ HE R-2 negative bre ast cancer cells (MCF-7 and MDA MB 231) a nd HER-2 positive cells (SK-Br-3 and BT474), and a Herceptin resistant BT474 cell line. (Month 6 -8) b. We will demo nstrate that the co njugated nanotubes photothera mlly-ablate Herc eptin po sitive brea st ca ncer cell s orthotopically implanted in athymic nude mice. (Month 9 -10) c. We will determine the optimized concentration of the conjugate for given depths within the mice. (Month 11-12) 
Task2a
The N-MWNT conjugates with herceptin mentioned above were put into solution with HER-2 negative breast cancer cells and MDA MB 231) and HER-2 positive cells (SK-Br-3 and BT474), and a Herceptin resistant BT474 cell lines. Using different concentrations and different wait times the well mixed cell-nanotube solutions were studied using light scattering to determine the level of binding and aggregation in the solutions. This was taken as an indication of specific binding between the cells and the nanotube conjugates. We determined that there was no difference between HER2 positive and HER2 negative cells indicating that the HER 2 was not being bound in the experiment. This is not surprising since the herceptin was previously determined to have become denatured due to the proximity of the nanotube. Upon further microscopic examination, we found no specific binding between the conjugated nanotubes and the HER 2 positive cells. Direct injection into MCF7 tumor xenographs were successful in removal of the tumors upon heating as reported previously and now in literature. However no specific targeting was achieved.
However the DNA (aptamer) encased nanotubes COULD be used in targeting. To test this a model was prepared to which the aptamer could target.
Task2b
All animal experiments were performed under the protocol approved by animal care committee of the Wake Forest University Baptist Medical Center. Tumor xenografts were generated by sub-cutaneous injection of 3 x 10 6 PC3 cells suspended in 100 µl of 1:1 PBS:Matrigel in both flanks of 12 male nude mice. Mice were used for experimental procedures two weeks following inoculation with tumor cells, after tumor size had reached 200 -250 mm 3 . Each of the 12 mice were treated with 100 µL of 500 µg/mL solution of DNA-encased MWNTs injected into the right-flank tumor and 100µl of sterile water injected into the left-flank tumor. After 1.5 h, the tumors on both flanks of 8 mice were irradiated using a NIR quasi-CW-YAG laser beam pulses with 5 sec on & 3 sec off for total exposure time 70 sec at the power level of 2.5W/cm 2 . The remaining four mice were treated identically but were not exposed to the laser. The tumor sizes were measured by a caliper every third day and photographs of tumors were taken once per week. The tumor volumes were calculated using the formula x * y 2 * pi/6 (where x and y are the long and short diameters of the tumor, respectively).
The tumors were analyzed as four independent groups: 1) No laser, no MWNT; 2) Laser, no MWNT; 3) No laser, MWNT; 4) Laser,
MWNT. The statistical significance of tumor volume measurements among the four groups were measured using SAS v. completely eradicated by day 6 following the single treatment ( Figure 6 ).
Statistical analysis of the tumor volume data revealed that the mean tumor size for the MWNT+laser group diverged from the mean values for the other three groups (laser-only; MWNT-only; no treatment) beginning on day 6 and persisting until the end of the study.
For example, comparison of the MWNT+laser to MWNT-only showed a statistical significance beginning on day 6 (p = 0.0109) that increased in significance at later time points (p < 0.0001 at day 24 and day 30). The MWNT+laser group showed similar statistical significance relative to the laser-only group (p < 0.0001 beginning on day 10 and persisting through the study) and the no treatment group (p < 0.0001 beginning on day 17). The three control groups (MWNT-only, laser only, no treatment) did not show a statistically significant difference in tumor volume at any time during the study (MWNT-only vs no treatment p = 0.6094 at day 30). Thus, the effectiveness of treatment requires both the presence of MWNTs and laser irradiation.
Those tumors that were both injected with DNA-encased MWNTs and irradiated with the nIR laser were completely eradicated by treatment. Tumors that received an MWNT-injection but were not lased did not display any different growth characteristics relative to untreated tumors. Similarly, tumors that were lased but that were not injected with MWNTs displayed growth characteristics indistinguishable from control tumors.
Tumors that received both an intratumoral injection of DNA-encased MWNTs and irradiation with a nIR laser displayed a minor surface burn to the skin. An antibiotic ointment was applied to the burned area and a scab formed over the burn. The scab fell off each of the tumors within 2-3 days of the lasing procedure and the area that had been occupied by the tumor completely healed over for all eight of the animals treated. In no case, was there any evidence of tumor re-growth nor was there any evidence of long-term damage to skin. The results indicate that DNA-encased MWNTs are useful for the selective thermal eradication of malignant or hyperproliferative tissue and that this can be accomplished without any long-term damage to adjacent normal tissue. During this experiment we discovered that herceptin conjugated N-doped MWNTs could not target HER2 positive breast cancer lines.
This was determined to be due to denatured herceptin. In order to provide some idea of the concept and its validity once a targeting meaty was successfully attached we were forced to switch to a PC3 mouse model using aptamers as the targeting method. The negative results of the herceptin conjugation was thusly turned into a positive demonstration of targeting using nanotubes conjugated with a DNA fragment.
There is considerable interest in the use of nanotechnology for cancer diagnosis and treatment with projected applications in drug delivery, imaging (de la Zerda et al., 2008) , and other areas. The present study has demonstrated that DNA-encased MWNTs that are soluble in aqueous solution (Zheng et al. 2002; Kam et al., 2005; Vogel et al., 2007) display thermal heating properties that are comparable to, and in several aspects superior to those displayed by non-derivatized MWNTs. Previous studies have demonstrated that SWNTs that have been solubilized by either DNA-encasement or with PEG may be excited upon irradiation with nIR to release heat sufficient for lethality towards cancer cells in tissue culture (Kam et al., 2005) . In the present study, we have demonstrated that the conversion of nIR irradiation to heat by DNA-encased MWNTs is linear with respect to both power and time indicating that control of these parameters can be exercised to provide the desired selectivity of cell kill in vivo. Further, we have demonstrated that DNA-encased MWNTs can be used for the selective eradication of malignant tissue in vivo.
